"Superpower peptides: cost, what's included and how it works"

Superpower is a real, clinician-led telehealth company, and its peptide offer is a preorder: BPC-157 or TB-500 at $149 a month, MOTS-c at $199, with a blood test and membership bundled in. A clinician must approve you, and the peptides page sets a late-November ship date that is still "pending pharmacy confirmation." These compounded products are not FDA-approved, and the federal policy behind them is interim.

That is the short version. Below is what the price covers, how the steps work, what Superpower's own pages say about refunds and states (two of its pages disagree), and the details it has not published yet. For the live numbers next to other programs, see our BPC-157 price page and our Superpower review.

What Superpower sells in peptides

Superpower's peptides page, read on October 30, 2026, lists six products. Three have a price and a preorder button; three are waitlist only.

The page's FAQ explains the timing: "You'll pay your first month when you pre-order" (Superpower). We keep the dollar figures in this table so they can be updated in one place; the live price table shows the same numbers next to every other program.

All six are among the peptides named in HHS's October 2026 interim policy. Our HHS peptide policy guide explains what that policy does and does not allow.

What the monthly price includes

Superpower bundles the drug with care. Its peptides page describes the package as "Your prescribed peptide, a blood test covering 40+ biomarkers, review by a licensed clinician who sets your protocol, and ongoing clinical guidance in the Superpower app." (Superpower)

No separate membership fee appears in the peptide checkout terms, so the monthly figure is the all-in number we use. The repeat lab work is the part most other peptide programs do not offer: of the programs we track, only Hone Health builds labs into its sermorelin price (see our sermorelin cost guide).

One difference worth knowing: the regular Superpower membership FAQ advertises "100+ biomarkers from one blood draw" (Superpower FAQ), while the peptide page says 40+. We read both on October 30, 2026. The peptide bundle may use a smaller panel than the standalone membership; Superpower does not explain the gap.

How it works, step by step

The peptides page lays out four steps:

1. Online assessment. You answer questions on goals, health history and current medications.
2. Clinician review. A US-licensed clinician decides whether a prescription is appropriate. The page states: "Each peptide requires a clinician's evaluation and prescription." (Superpower)
3. Pharmacy. If you are prescribed, a US-licensed pharmacy compounds the drug for you by name and ships it. The page says prescriptions are "compounded to order" and filled by "US-licensed pharmacies" (Superpower).
4. Membership activation. You book the blood draw and follow up with the care team in the app.

The billing sits on top of that: "Medication is charged up front as a preorder" (Superpower). The clinician review happens later, "when we're ready to ship," and if you are approved, "your next payment will be charged 30 days after approval, then every 30 days after that." (Superpower)

So you pay before anyone has reviewed your case. That is the trade for a place in the queue.

Refunds: two Superpower pages say different things

The peptides page says: "If you're not approved for a prescription, you get a full refund" (Superpower). The general membership FAQ says: "Superpower does not offer refunds at this time." (Superpower FAQ)

We read both pages on October 30, 2026. Neither is dated. The peptide wording is narrower (it covers not being approved) and newer in context, since the peptide launch followed HHS's October 28 policy. Our reading is that the peptide terms apply to peptide preorders, but that is an inference. Before you pay, ask Superpower in writing what happens if you change your mind after approval, or if the late-November ship date slips.

Did Superpower say it would not sell BPC-157?

Yes, earlier. Superpower's own guide "What Are Peptides?", published April 23, 2026 and last updated September 1, 2026, still states that the company "does not sell, prescribe, or facilitate access to any branded version, or to research-only peptides such as BPC-157, TB-500, MOTS-c, and Melanotan II." (Superpower guide)

The peptides page, read on October 30, 2026, now sells BPC-157, TB-500 and MOTS-c. The change lines up with the HHS policy filed on October 28, 2026, which says HHS "does not intend to take enforcement action against a State-licensed pharmacy, Federal facility, or licensed physician compounding a drug product using a peptide bulk drug substance found in Appendix A." (Federal Register) The older guide simply has not been updated. Treat the peptides page as the current offer.

Is Superpower legit?

Here is what we could check, and what we could not.

• Who runs it. Superpower Health, Inc., per the footer of its own pages. Its Series A round was "led by Forerunner Ventures" (Superpower), which TechCrunch reported in April 2025 alongside its public launch, describing a "Series A funding round led by Forerunner" (TechCrunch).
• LegitScript. Superpower's FAQ says "Superpower is LegitScript certified" (Superpower FAQ). LegitScript's public lookup sits behind a reCAPTCHA, so we could not confirm the certificate with an automated check. You can look it up yourself on LegitScript's certification lookup.
• FDA warning letters. We searched FDA's warning-letter database for "Superpower" on October 30, 2026 and found none (search checked against a control term that did return letters).
• Pharmacies. The FAQ names partner pharmacies: "These include Strive Pharmacy, Belmar Pharmacy, and Progress Pharmacy." (Superpower FAQ) It does not say which one fills each peptide.
• Litigation. Function Health, a rival testing company, sued Superpower in January 2026. A law-firm summary describes a complaint "alleging false advertising and unfair competition under the federal Lanham Act and California state law" over its biomarker claims (ArentFox Schiff). These are allegations, not findings, and we found no ruling. The case is about lab-testing marketing, not peptides.
• The product itself. Superpower is candid that its launch peptides are experimental: "The peptides in this launch are investigational," and "The initial BPC-157, TB-500 and MOTS-c products are not FDA-approved." (Superpower)

On the evidence we could read, Superpower is a legitimate business running a clinician-gated program. Whether the drug is worth taking is a separate question. Human evidence for BPC-157 is very limited; our BPC-157 side effects guide covers what is and is not known.

What Superpower has not published

These are the gaps we would want closed before prepaying:

• Which pharmacy compounds each peptide, and whether it is a 503A pharmacy (the HHS policy covers 503A compounding only).
• Vial size and how long a vial lasts. Only a monthly price is shown. Dose is your clinician's decision, and we do not cover it.
• A peptide-specific state list. The FAQ's general service list excludes nine states: "Alaska, Arkansas, Hawaii, Louisiana, Mississippi, North Dakota, Rhode Island, South Dakota, and Wyoming." (Superpower FAQ) The peptides page names no state exclusions of its own, and state pharmacy boards are not bound by the HHS policy.
• A firm ship date. "Late November, pending pharmacy confirmation" is a target.
• Insurance. The FAQ says it does not take insurance but may be HSA/FSA eligible.

The regulatory fine print

Compounded drugs are not FDA-approved. The Federal Register notice says so directly: "Compounded drugs are not FDA-approved, which means FDA does not review their safety, effectiveness, or quality before they are marketed." (Federal Register) The same notice says HHS "may revisit application of this interim policy (in whole or in part) if, among other things, a safety signal or product quality issue arises" and that it "is not binding on HHS or the public." We checked this on October 30, 2026. If the policy is withdrawn, Superpower's peptide line could end. Our guide is BPC-157 legal? tracks the status.

FAQ

Superpower peptides: what do they cost and what's included?

BPC-157 and TB-500 are listed at $149 a month and MOTS-c at $199, per Superpower's peptides page read on October 30, 2026. The first month is charged at preorder. The price includes clinician review, the compounded peptide, a 40+ biomarker blood test, the membership and app messaging, with CBC and CMP labs every six months while treatment continues.

Does Superpower sell BPC-157?

Superpower takes preorders for injectable BPC-157 as of October 30, 2026, with a target ship date in late November that is pending pharmacy confirmation. An older Superpower guide, last updated September 1, 2026, says it does not sell BPC-157. That guide predates the HHS policy of October 28, 2026; the peptides page is the current offer.

Is Superpower legit?

Superpower is an operating telehealth company with a Forerunner-led Series A, named partner pharmacies, and no FDA warning letter we could find on October 30, 2026. It says it is LegitScript certified; we could not confirm that automatically. A rival's false-advertising lawsuit over biomarker claims is pending. Its peptides are investigational and not FDA-approved.

Can I get a refund from Superpower?

The peptides page promises a full refund if a clinician does not approve your prescription. The general FAQ says Superpower does not offer refunds at this time. Both were read on October 30, 2026. Ask Superpower in writing how the preorder refund works if you cancel after approval or if shipping is delayed.

Which states can't use Superpower?

Its FAQ lists nine states where the service is not available: Alaska, Arkansas, Hawaii, Louisiana, Mississippi, North Dakota, Rhode Island, South Dakota and Wyoming. That is the company-wide list. The peptides page does not give a separate state list, so confirm your state during the assessment.

Is Superpower BPC-157 FDA-approved?

No. Superpower itself says its initial BPC-157, TB-500 and MOTS-c products are not FDA-approved. They are compounded under an interim HHS enforcement-discretion policy, which HHS says can be revisited and does not bind anyone. We checked the policy on October 30, 2026.

Compare Superpower with every other program on our peptide price table, or see our ranked best peptide programs.